Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder

This randomized, double-blind, placebo-controlled trial evaluated the effects of a 300 µg/day testosterone patch on hypoactive sexual desire disorder (HSDD) in surgically menopausal women receiving estrogen therapy. Over 24 weeks, the testosterone group experienced significant increases in satisfying sexual activity (mean increase of 1.56 episodes per 4 weeks vs. 0.73